NO952291L - Nye triazolopyrimidoner, deres fremstilling og deres anvendelse - Google Patents

Nye triazolopyrimidoner, deres fremstilling og deres anvendelse

Info

Publication number
NO952291L
NO952291L NO952291A NO952291A NO952291L NO 952291 L NO952291 L NO 952291L NO 952291 A NO952291 A NO 952291A NO 952291 A NO952291 A NO 952291A NO 952291 L NO952291 L NO 952291L
Authority
NO
Norway
Prior art keywords
preparation
novel
triazolopyrimidones
triazolopyrimidines
formula
Prior art date
Application number
NO952291A
Other languages
English (en)
Norwegian (no)
Other versions
NO952291D0 (no
Inventor
Rainer Schlecker
Hans-Joerg Treiber
Berthold Behl
Hans Peter Hofmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO952291L publication Critical patent/NO952291L/no
Publication of NO952291D0 publication Critical patent/NO952291D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO952291A 1992-12-10 1995-06-09 Nye triazolopyrimidoner, deres fremstilling og deres anvendelse NO952291D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241562A DE4241562A1 (de) 1992-12-10 1992-12-10 Neue Triazolopyrimidone, ihre Herstellung und Verwendung
PCT/EP1993/003332 WO1994013673A1 (de) 1992-12-10 1993-11-27 Neue triazolopyrimidone, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO952291L true NO952291L (no) 1995-06-09
NO952291D0 NO952291D0 (no) 1995-06-09

Family

ID=6474848

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952291A NO952291D0 (no) 1992-12-10 1995-06-09 Nye triazolopyrimidoner, deres fremstilling og deres anvendelse

Country Status (22)

Country Link
US (1) US5654310A (sv)
EP (1) EP0673378B1 (sv)
JP (1) JP3490445B2 (sv)
CN (1) CN1098414A (sv)
AT (1) ATE150023T1 (sv)
AU (1) AU674371B2 (sv)
CA (1) CA2151243A1 (sv)
CZ (1) CZ144995A3 (sv)
DE (2) DE4241562A1 (sv)
DK (1) DK0673378T3 (sv)
ES (1) ES2099577T3 (sv)
FI (1) FI952856A0 (sv)
GR (1) GR3022980T3 (sv)
HU (1) HUT72300A (sv)
IL (1) IL107916A (sv)
MX (1) MX9307735A (sv)
NO (1) NO952291D0 (sv)
NZ (1) NZ258558A (sv)
PL (1) PL309329A1 (sv)
RU (1) RU95121818A (sv)
WO (1) WO1994013673A1 (sv)
ZA (1) ZA939228B (sv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053600A (en) * 1973-03-08 1977-10-11 Sandoz, Inc. Tricyclic 1,2,4-triazolo-quinazolines
US4128644A (en) * 1977-07-29 1978-12-05 E. R. Squibb & Sons, Inc. Pyrazolo(1,5-c)quinazoline derivatives and related compounds
DE3146599A1 (de) * 1981-11-25 1983-07-07 Basf Ag, 6700 Ludwigshafen Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE3677445D1 (de) * 1985-09-30 1991-03-14 Ciba Geigy Ag 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof

Also Published As

Publication number Publication date
ZA939228B (en) 1995-06-09
JP3490445B2 (ja) 2004-01-26
CA2151243A1 (en) 1994-06-23
NZ258558A (en) 1997-06-24
AU674371B2 (en) 1996-12-19
MX9307735A (es) 1994-06-30
DE4241562A1 (de) 1994-06-16
HUT72300A (en) 1996-04-29
HU9501692D0 (en) 1995-08-28
WO1994013673A1 (de) 1994-06-23
FI952856A (sv) 1995-06-09
CZ144995A3 (en) 1995-12-13
ES2099577T3 (es) 1997-05-16
AU5628594A (en) 1994-07-04
US5654310A (en) 1997-08-05
EP0673378B1 (de) 1997-03-12
ATE150023T1 (de) 1997-03-15
DE59305812D1 (de) 1997-04-17
PL309329A1 (en) 1995-10-02
FI952856A0 (sv) 1995-06-09
IL107916A0 (en) 1994-04-12
EP0673378A1 (de) 1995-09-27
CN1098414A (zh) 1995-02-08
JPH08504412A (ja) 1996-05-14
GR3022980T3 (en) 1997-06-30
IL107916A (en) 1996-09-12
RU95121818A (ru) 1997-06-10
DK0673378T3 (da) 1997-07-21
NO952291D0 (no) 1995-06-09

Similar Documents

Publication Publication Date Title
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
DK0553890T3 (da) Diphenylheteroalkylderivater, deres fremstilling og lægemidler og kosmetisk fremstillet derudfra
TW261616B (sv)
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
NO954328L (no) Nye substituerte 1-fenyl-pyridinyl-benzotriazoler
DK0596891T3 (da) Aminoalkylsubstituerede 2-amino-5-mercaptothiadiazoler, deres fremstilling og anvendelse
DK0589903T3 (da) Aminoalkylsubstituerede 5-mercaptothiazoler, deres fremstilling og anvendelse
NO952291L (no) Nye triazolopyrimidoner, deres fremstilling og deres anvendelse
DK0589908T3 (da) Aminoalkylsubsituerede thiazolin-2-oner, deres fremstilling og deres anvendelse
DK0512522T3 (da) Nye antibiotiske forbindelser og deres fremstilling
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
DK0592453T3 (da) Aminoalkylsubstituerede 2-amino-1,3,4-thiadiazoler, deres fremstilling og deres anvendelse
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
NO952292L (no) Nye triazolokinazoliner, deres fremstilling og anvendelse
CA2177602A1 (en) N-substituted azabicycloalkane derivatives, their preparation and use